Should Biotechnology Stock Cidara Therapeutics Inc (CDTX) Be in Your Portfolio Friday?

Cidara Therapeutics Inc (CDTX) is around the top of the Biotechnology industry according to InvestorsObserver. CDTX received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. Cidara Therapeutics Inc also achieved a score of 85 in the Biotechnology industry, putting it above 85 percent of Biotechnology stocks. Biotechnology is ranked 76 out of the 148 industries.

CDTX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on CDTX!

See Full CDTX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cidara Therapeutics Inc Stock Today?

Cidara Therapeutics Inc (CDTX) stock is unchanged -0.27% while the S&P 500 is down -0.56% as of 1:22 PM on Friday, Oct 13. CDTX is unchanged $0.00 from the previous closing price of $0.92 on volume of 327,019 shares. Over the past year the S&P 500 has gained 17.86% while CDTX has risen 55.93%. CDTX lost -$0.16 per share the over the last 12 months. Click Here to get the full Stock Report for Cidara Therapeutics Inc stock.